Purple Biotech Stock Technical Analysis
| PPBT Stock | USD 0.60 0.02 2.58% |
As of the 31st of January, Purple Biotech holds the Risk Adjusted Performance of 0.0432, semi deviation of 4.32, and Coefficient Of Variation of 2142.65. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Purple Biotech, as well as the relationship between them.
Purple Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Purple, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PurplePurple Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Purple Biotech Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 34.0 | Buy | 1 | Odds |
Most Purple analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Purple stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Purple Biotech, talking to its executives and customers, or listening to Purple conference calls.
Is there potential for Biotechnology market expansion? Will Purple introduce new products? Factors like these will boost the valuation of Purple Biotech. Anticipated expansion of Purple directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Purple Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Purple Biotech's market price often diverges from its book value, the accounting figure shown on Purple's balance sheet. Smart investors calculate Purple Biotech's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Purple Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Purple Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Purple Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Purple Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Purple Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Purple Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Purple Biotech.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Purple Biotech on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Purple Biotech or generate 0.0% return on investment in Purple Biotech over 90 days. Purple Biotech is related to or competes with Gilead Sciences, Sanofi ADR, Amgen, GlaxoSmithKline PLC, Bristol Myers, Stryker, and Boston Scientific. Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug... More
Purple Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Purple Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Purple Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.19 | |||
| Information Ratio | 0.0412 | |||
| Maximum Drawdown | 98.72 | |||
| Value At Risk | (8.54) | |||
| Potential Upside | 8.86 |
Purple Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Purple Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Purple Biotech's standard deviation. In reality, there are many statistical measures that can use Purple Biotech historical prices to predict the future Purple Biotech's volatility.| Risk Adjusted Performance | 0.0432 | |||
| Jensen Alpha | 0.5169 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.0896 | |||
| Treynor Ratio | (36.87) |
Purple Biotech January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0432 | |||
| Market Risk Adjusted Performance | (36.86) | |||
| Mean Deviation | 4.72 | |||
| Semi Deviation | 4.32 | |||
| Downside Deviation | 5.19 | |||
| Coefficient Of Variation | 2142.65 | |||
| Standard Deviation | 11.27 | |||
| Variance | 127.09 | |||
| Information Ratio | 0.0412 | |||
| Jensen Alpha | 0.5169 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.0896 | |||
| Treynor Ratio | (36.87) | |||
| Maximum Drawdown | 98.72 | |||
| Value At Risk | (8.54) | |||
| Potential Upside | 8.86 | |||
| Downside Variance | 26.94 | |||
| Semi Variance | 18.62 | |||
| Expected Short fall | (8.32) | |||
| Skewness | 6.09 | |||
| Kurtosis | 44.79 |
Purple Biotech Backtested Returns
Purple Biotech maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Purple Biotech exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Purple Biotech's Risk Adjusted Performance of 0.0432, coefficient of variation of 2142.65, and Semi Deviation of 4.32 to confirm the risk estimate we provide. The company holds a Beta of -0.014, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Purple Biotech are expected to decrease at a much lower rate. During the bear market, Purple Biotech is likely to outperform the market. At this point, Purple Biotech has a negative expected return of -0.5%. Please make sure to check Purple Biotech's potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Purple Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.17 |
Very weak predictability
Purple Biotech has very weak predictability. Overlapping area represents the amount of predictability between Purple Biotech time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Purple Biotech price movement. The serial correlation of 0.17 indicates that over 17.0% of current Purple Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Purple Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Purple Biotech Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Purple Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Purple Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Purple Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Purple Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Purple Biotech price pattern first instead of the macroeconomic environment surrounding Purple Biotech. By analyzing Purple Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Purple Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Purple Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.1 | 0.088 | Price To Sales Ratio | 132.08 | 92.33 |
Purple Biotech January 31, 2026 Technical Indicators
Most technical analysis of Purple help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Purple from various momentum indicators to cycle indicators. When you analyze Purple charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0432 | |||
| Market Risk Adjusted Performance | (36.86) | |||
| Mean Deviation | 4.72 | |||
| Semi Deviation | 4.32 | |||
| Downside Deviation | 5.19 | |||
| Coefficient Of Variation | 2142.65 | |||
| Standard Deviation | 11.27 | |||
| Variance | 127.09 | |||
| Information Ratio | 0.0412 | |||
| Jensen Alpha | 0.5169 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.0896 | |||
| Treynor Ratio | (36.87) | |||
| Maximum Drawdown | 98.72 | |||
| Value At Risk | (8.54) | |||
| Potential Upside | 8.86 | |||
| Downside Variance | 26.94 | |||
| Semi Variance | 18.62 | |||
| Expected Short fall | (8.32) | |||
| Skewness | 6.09 | |||
| Kurtosis | 44.79 |
Purple Biotech January 31, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Purple stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | (0.40) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 0.62 | ||
| Day Typical Price | 0.61 | ||
| Price Action Indicator | (0.02) | ||
| Market Facilitation Index | 0.04 |
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.